Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BYNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis

9 more authors
  1. 1Shinagawa R&D Center, Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan
  2. 2Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan

Related

  1. Ravulizumab for AChR antibody-positive generalized myasthenia gravis in the United Arab Emirates: a real-world case series
    Sidra Aurangzeb, Ali Mohamed Hassan, Ahmed Mahmoud Hassan +6
    Frontiers in NeurologyPeer-reviewedCC BY 4.0NeurologyCrossref
  2. Optimization of a Human Anti-polio Monoclonal Antibody as a Potential Therapeutic Modality
    S.-M. Lee, C. Siska, I. D'Angelo +2
    bioRxivPreprintCC BYFull textMedical imaging & radiologybioRxiv
  3. Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis
    Aisling McGuigan, Hannah A. Blair
    CNS DrugsPeer-reviewedCC BY-NC 4.0Full textNeurologyPMC
  4. Beyond the Classic Triad: A Case of GQ1b Antibody-Positive Bickerstaff Brainstem Encephalitis Overlap Syndrome
    Jarod T Ormsby, Ajay McLaughlin, Antoni Wojtkowski +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Ventricular fibrillation treated by an implantable cardioverter-defibrillator in antimitochondrial M2 antibody-positive myocarditis.
    Kanto Saida, Atsushi Sudo, Takunori Aoyama +2
    HeartRhythm case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
BibTeX
@article{yamamoto2026musk,
  title = {{MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis}},
  author = {Kentaro Yamamoto and Akiyuki Uzawa and Genta Narazaki and Yoshikazu Nezu and Mami Yamazaki and Hirofumi Kondo and Kozo Yoneda and Masaya Shimada and Chigusa Yoshimura and Yoko Nakano and Manato Yasuda and Hiroyuki Akamine and Yosuke Onishi and Hideo Handa and Etsuko Ogaya and Tomonori Kunikata and Ryutaro Nakashima and Hidenori Takahashi and Tomohiro Nishizawa and Satoshi Kuwabara and Kiyosumi Takaishi},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13673047},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis
AU  - Kentaro Yamamoto
AU  - Akiyuki Uzawa
AU  - Genta Narazaki
AU  - Yoshikazu Nezu
AU  - Mami Yamazaki
AU  - Hirofumi Kondo
AU  - Kozo Yoneda
AU  - Masaya Shimada
AU  - Chigusa Yoshimura
AU  - Yoko Nakano
AU  - Manato Yasuda
AU  - Hiroyuki Akamine
AU  - Yosuke Onishi
AU  - Hideo Handa
AU  - Etsuko Ogaya
AU  - Tomonori Kunikata
AU  - Ryutaro Nakashima
AU  - Hidenori Takahashi
AU  - Tomohiro Nishizawa
AU  - Satoshi Kuwabara
AU  - Kiyosumi Takaishi
PY  - 2026
DA  - 2026/10/01
JO  - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
UR  - https://europepmc.org/article/PMC/PMC13673047
SN  - 1933-7213
SN  - 1878-7479
ER  -